Skip to main content

E2F4DN como agente geroterapéutico para el envejecimiento cerebral (GeroE2F4DN)

PLEC2022-009385

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Líneas Estratégicas
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Brain region lipidomics and marine lipid intake in an aging rodent model

  • Lois, Salomé
  • Castro, Verónica
  • González, M. Jesús
  • Medina, Isabel
11th Workshop in Lipidomics, Marine Lipidomics, online meeting, May 3rd 2023, One of the most notable questions in neurobiology remains with the selective targeting of specific brain regions by different neurodegenerative diseases. The understanding of this selective phenomenon will contribute to the development of targeted therapeutic approaches that specifically protect affected neurons. The present work shows the lipid mapping of the rat brain for an aging model focusing lipid composition and oxylipins. Considering the intake of fish oils, the study evaluates the requirement of DHA for normal brain development and function, and the formation of lipid mediators, specially those resolvers of inflammation. Both of these issues are rising as crucial for the health effects of fish oil in the progression of inflammation and brain aging. Aging experiments were performed in wild type mice fed standard diet enriched with fish oils. Brain cortex, basal ganglia and cerebellum were analysed for fatty acid composition, plasmalogens, lipid classes and lipid mediators. Results demonstrated that aging reduced fat content in the three regions, and the supplementation with fish oils was able to revert this trend. Additionally, aging leads a pro-inflammatory phenotype, especially in brain cortex. Accordingly, aging leads an increase of the formation of proinflammatory dihydroxides, Prostaglandins and other arachidonic derivatives through the activity of COX and sEH. Additionally, there was a selective effect of aging in the loss of anti-inflammatory lipid metabolites as those resulting from the activation of LOX over DHA and EPA. The intake of marine oils reverts this proinflammatory phenotype leading an antiinflammatory stage with a significant formation of specialised resolvers in inflammation. This effect was predominant in brain cortex than in cerebellum or basal ganglia. Therefore, these results reveal pathways related with mental diseases and metabolic disorders that are specifically modulated by fat intake in the different Brain Regions. A better understanding of selective vulnerability is required for the development of targeted nutrient and therapeutic approaches, This work was supported by the Spanish Ministry of Science and Innovation (grant RTI2018- 095659-B-I00 and PLEC2022-009385), No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Marine Lipids Intake as Dietary Strategy to complement Gene Therapies targeting Neurodegeneration

  • Freiría-Martínez, Luis
  • Miralles-Pérez, Bernat
  • Lois, Salomé
  • López, N.
  • Méndez, Lucía
  • Frade, J. M.
  • Medina, Isabel
Omega Marine Lipids Workshop – Enhancing the exploration and analysis of marine-derived lipids for healthy and sustainable diets, 16-18 June 2025, Aviero, Dietary marine lipids enriched in ω-3 polyunsaturated fatty acids (PUFAs), mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are spotlighted for favourable effects in neurodegenerative conditions. In this healthy effect, the role of ω-3 PUFA on resolution of inflammation through the production of lipid metabolites seems to be decisive, as failure to resolve inflammation can result in excessive, inappropriate, or ongoing processes that can lead to pathology and disease. In this field, neuroinflammation and oxidative stress are common and interrelated hallmarks of neurogenerative diseases. Lipid metabolism is affected by oxidative stress and unbalanced production of lipid metabolites can be one of the main disease triggers, This work was supported by the Spanish Ministry of Science, Innovation and Universities grant number PLEC2022-009385, and the Xunta de Galicia—Axencia Galega de Innovación (GAIN) (IN6076CB20231/0503)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Krill and Squid Oils Exhibit Different Benefits from Fish Oil on Cognitive Performance in Aged Mice

  • Miralles-Pérez, Bernat
  • Freiría-Martínez, Luis
  • Méndez, Lucía
  • Lois, Salomé
  • Sánchez-Martos, Vanessa
  • Romeu, Marta
  • Medina, Isabel
20th Euro Fed Lipid Congress and Expo, From Insight to Impact: Advancing Sustainability in Fats, Oils, and Lipids, 12-15 October 2025, Leipzig, Germany, The present study aimed to delve into the ability of marine oils, derived from different sources, which rend polar and apolar lipids, as supplements for preserving cognitive performance and brain health in an aged C57BL/6J mouse model. To achieve this, we focused on the molecular mechanisms underlying oxidative stress and chronic inflammation as common features associated with the aging process and linked to neurodegenerative disorders. As for the experimental model, krill and squid oils enriched in omega-3 polyunsaturated fatty acids (PUFAs)-containing phospholipids (PLs) versus sardine and salmon oils enriched in omega-3 PUFAs-containing triacylglycerides (TGs) were tested in a once per week supplementation in adult mice during six months. After this period, animals were sacrificed and we focused on the brain cortex as target of the loss of brain performance. Lipidomics and Proteomics platforms together with clinical and behavioural tests were employed in a holistic study of the dietary modulation. Then, oxidative stress in the brain cortex was evaluated through the glutathione system, protein carbonylation and lipid peroxidation. Inflammation was studied by mapping lipid mediators, eicosanoids, and docosanoids. Loss of cognitive capacities were evaluated through Morris Water Maze tests. Results widely demonstrated the benefits of marine oils to preserve cognitive performance in aged mice, along with specific carbonylated proteins and anti-inflammatory phenotypes characterised by the significant formation of lipid mediators that act as resolvers of inflammation. The best results were achieved after supplementation with marine oils containing omega-3 PUFAs in the form of PLs. These data suggest that the bioactivity of marine oils on brain health during aging depends not only on the amount of PUFAs consumed but also on the form in which n-3 PUFAs are administered, This study was supported by the Spanish Ministry of Science, Innovation and Universities (grant numbers: PLEC2022-009385, RTI2018-095659-B-I00), and the Xunta de Galicia—Axencia Galega de Innovación (GAIN) (grant number: IN6076CB20231/0503), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Targeting dysregulated Brain Lipid Metabolism is Essential for Gene Therapy Treatment of Alzheimer's Disease

  • Freiría-Martínez, Luis
  • Miralles-Pérez, Bernat
  • Lois, Salomé
  • López, N.
  • Méndez, Lucía
  • Frade, J. M.
  • Medina, Isabel
20th Euro Fed Lipid Congress and Expo, From Insight to Impact: Advancing Sustainability in Fats, Oils, and Lipids, 12-15 October 2025, Leipzig, Germany, The complex ethology of Alzheimer’s disease (AD) with neuroinflammation as a relevant central mechanism requires a multifactorial approach for an efficient treatment. Recent evidence is showing the positive effects of gene therapies based on transcription factors that regulate cell quiescence and tissue homeostasis, and control gene networks affected in AD. In this field, lipid disruption is emerging as a key point to address and abnormal lipid metabolism and it is suggested to be closely linked with the progress of AD. Oxidized lipid metabolites, in particular, proinflammatory eicosanoids and oxidized cholesterol, in the form of oxysterols, seem to be one of the main triggers of AD. Accumulation of lipid metabolites in brain is controlled by various enzymatic pathways, but compromised elimination of lipid waste is sufficient to trigger accumulation and to deliver pro-inflammation and neurotoxic conditions. This works aims to deep inside the unregulated metabolism of brain cortex lipids of a murine model of Alzheimer’s disease (5xFAD mice). Through lipidomic platforms, we have targeted the profiling of lipid metabolites coming from enzymatic and non-enzymatic oxidation of brain lipids and fatty acids, together to unregulated lipid accumulation. A strong pro-inflammatory lipid-derived phenotype lead by the presence of an excess of ARA-lipid mediators and an unbalanced cholesterol metabolism was clearly associated to the 5xFAD model. The work also presents the effect of a directed gene therapy based on E2F4, a transcription factor proposed as a major regulator of most AD-specific gene networks, on this lipid dysregulation. When expressed in neurons, a modified form of this factor, unable to become phosphorylated, has proved to recover the pathological phenotype of AD murine models. Our results bring evidence of the multifactorial effectiveness of the gene therapy by reverting the deleterious effects on brain lipid accumulation and metabolism. The study suggests the strong potential of Maresins and Lipoxins derived from the metabolism of DHA to contribute to the beneficial effect of the gene therapy. Lipidomic results are accompanied with Redox Proteomics findings, which highly support the effectiveness of gene therapies for a multifactorial targeting of AD, This work was supported by the Spanish Ministry of Science, Innovation and Universities grant number PLEC2022-009385, and the Xunta de Galicia—Axencia Galega de Innovación (GAIN) (IN6076CB20231/0503)., Peer reviewed